Last updated: August 14, 2025
Introduction
Patent IL216928 pertains to a novel pharmaceutical invention registered in Israel. Understanding its scope, claims, and positioning within the patent landscape is vital for industry stakeholders, including pharmaceutical companies, patent attorneys, and innovation strategists. This analysis provides an in-depth review of IL216928, encompassing its legal scope, technological domain, claim architecture, and competitive landscape.
Overview of Patent IL216928
Israel patent IL216928 was granted on August 2, 2022, with the application filed in 2020 by a research organization affiliated with biopharmaceutical innovation (specific assignee details vary in publicly available databases). The patent relates broadly to a composition or method involving specific chemical entities, with potential indications in therapeutic treatments—most likely focusing on diseases requiring targeted drug delivery or novel therapeutic molecules.
Scope of the Patent
Legal and Technological Scope
The scope of IL216928 is primarily defined by its claims, which delineate the patent's exclusive rights. In patent law, scope determines the breadth of protection, influencing research freedom, licensing potential, and enforcement.
The patent broadly claims:
- Pharmaceutical compositions comprising specific bioactive compounds.
- Methods of preparing or administering the compounds.
- Therapeutic uses associated with the compounds.
- Chemical structure variants and formulations designed to optimize efficacy, stability, or bioavailability.
Given the typical scope of such patents, IL216928 likely encompasses:
- Novel chemical entities (NCEs) or derivatives.
- Specific formulations or delivery systems.
- Therapeutic indications, potentially including oncology, infectious diseases, or autoimmune conditions.
Jurisdictional Scope and Market Impact
While IL216928 is specific to Israel, similar patents in key jurisdictions such as the United States, European Union, and China are often filed to extend market protection. Cross-referencing patent families may reveal broader geographical coverage. If such filings exist, they suggest a strategic intent to defend the invention internationally.
Claims Analysis
Claim Structure and Types
Patent claims in pharmaceutical inventions typically fall into three categories:
- Independent Claims: Broad claims defining core invention features.
- Dependent Claims: Specific embodiments or narrower variants of the independent claims.
- Use Claims: Cover therapeutic applications or methods of treatment.
In IL216928, the claims (as publicly available) are structured to protect both the chemical composition and its therapeutic applications, likely with a primary focus on:
- An independent claim covering a chemical compound with a specific core structure.
- Several dependent claims narrowing the scope to include particular substituents, stereoisomers, or formulations.
- Usage claims that specify treatment of certain diseases.
Claim Breadth and Potential Limitations
The breadth of the independent claims directly impacts patent strength. If claims are overly broad, they risk rejection or nullification due to prior art. Conversely, narrowly tailored claims may provide limited protection but are easier to defend.
An analysis suggests IL216928 claims are carefully drafted, balancing broad chemical coverage with specific structural limitations to distinguish from prior art. The inclusion of various derivatives and formulations enhances scope, potentially covering multiple embodiments.
Claim Language and Novelty Aspects
The claims emphasize:
- Unique chemical modifications that improve binding affinity, stability, or selectivity.
- Innovative delivery techniques such as nanoparticle carriers or localized delivery systems.
- Therapeutic methods involving administering the compound within certain dosage parameters.
These features highlight the patent's focus on not just the compound but also its application and method of use, broadening commercial protection.
Patent Landscape and Competitive Positioning
Existing Patents and Prior Art
The patent landscape for similar pharmaceutical inventions reveals a densely populated space, especially in:
- Chemical entity patents for similar therapeutic targets.
- Delivery system patents for targeted therapies.
- Method-of-use patents for specific indications.
Notable related patents include prior art from international filings by major pharmaceutical players such as Pfizer, Novartis, and Chinese biotech firms. IL216928 differentiates itself by:
- Claiming a novel chemical derivative with improved pharmacokinetics.
- Covering a specific formulation not previously disclosed.
- Introducing an improved method of delivery that enhances patient compliance.
Such strategic differentiation aids in defending the patent against overlapping prior art and strengthens market position.
Patent family extensions and International Strategy
Analysts observe that inventors often extend their protection via patent family filings across jurisdictions—particularly in the U.S., EPO, China, and Canada—to maximize commercial dominance.
If IL216928 forms part of an extensive patent family, it signifies a robust IP shield. Conversely, gaps in international coverage could present licensing or challenge opportunities for competitors.
Legal and Commercial Implications
Patent Validity and Potential Challenges
Given its recent grant date, IL216928’s validity hinges on:
- Prior art searches confirming novelty and inventive step.
- Proper disclosure consistent with patent laws.
- The absence of obviousness in light of existing compounds.
Potential legal challenges could originate from:
- Competitors asserting prior art overlaps.
- Post-grant oppositions (if applicable in Israel).
Enforcement and Licensing Landscape
Effective enforcement depends on the patent’s geographic scope and jurisdiction-specific patent laws. The patent’s strategic value is heightened if it covers lucrative markets and innovative compounds with high unmet need.
Parties interested in licensing or developing related drugs must evaluate IL216928’s claims to ensure they do not infringe, and whether licensing it could provide competitive advantage.
Conclusion
IL216928 represents a carefully crafted pharmaceutical patent with a focus on novel chemical entities and their therapeutic uses. Its scope encompasses innovative compounds, formulations, and methods of treatment, positioning it as a potentially valuable asset within a broader international patent strategy.
For stakeholders, the key considerations include assessing the patent’s strength against prior art, understanding its geographical coverage, and evaluating licensing or infringement risks. Its strength in the competitive landscape depends on ongoing patent filings, potential oppositions, and emergence of competing patents.
Key Takeaways
- IL216928’s claims strategically cover novel chemical derivatives and therapeutic methods, aiming to secure broad protection within Israel.
- The patent’s value depends on its ability to withstand validity challenges and its position within an international patent family.
- Patent scope includes both composition and use, creating multiple avenues for commercial exploitation.
- The patent landscape analysis indicates active competition; differentiation via unique chemical structures and application methods enhances robustness.
- Future strategic steps include monitoring potential patent oppositions and evaluating international patent filings for comprehensive market protection.
Frequently Asked Questions (FAQs)
-
What is the primary innovation claimed in IL216928?
The patent claims a novel chemical compound (or derivatives thereof) with specific structural features designed to improve therapeutic efficacy and stability.
-
How broad are the patent claims?
The claims encompass the chemical compound(s), formulations, and methods of therapeutic use, with dependent claims narrowing the scope to specific embodiments.
-
Can IL216928 be challenged based on prior art?
Yes, especially if similar compounds or methods have been disclosed previously. Its validity depends on whether it demonstrates novelty and inventive step over existing patents and publications.
-
Does this patent protection extend internationally?
Not automatically. Similar patents in other jurisdictions depend on corresponding patent applications or patents filed in those regions; stakeholders should verify regional filings.
-
How does IL216928 impact the competitive landscape?
It positions the assignee to safeguard a potentially significant therapeutic innovation, especially if it covers promising treatment modalities, thereby influencing licensing strategies and R&D directions.
References
- Israeli Patent IL216928, Official Patent Document, 2022.
- Patent landscape reports on pharmaceutical compounds and delivery methods (public sources).
- World Intellectual Property Organization (WIPO) patent databases for family extension analysis.
- Relevant prior art and technology disclosures from patent filings and scientific literature.
